Citations 1
Re-exposure to blinatumomab after CD19-positive relapse: Experience from three trials in patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R ALL).
Topp, Max S. , Stelljes, Matthias , Barnette, Phillip, Heffner, Leonard T., Trippett, Tanya, Bargou, Ralf C. , Holland, Chris, Litzow, Mark R. , Zugmaier, Gerhard , Benjamin, Jonathan
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7051-7051
